Hive Health

Hive Health Competitive Intelligence & Landscape

ourhivehealth.com ·

Overview

Hive Health Overview

HealthHive is a healthcare technology company focused on improving care coordination and management for aging adults and their informal care teams. Founded in 2018 and headquartered in Short Hills, United States, the company develops a patient-centered B2B SaaS platform that integrates health records, care plans, social information, and communication tools to support a community of caring (Exa). The platform aims to bridge gaps in care planning, coordination, and long-term care management by seamlessly integrating into existing healthcare systems without disrupting organizational workflows.

As a Public Benefit Corporation, HealthHive emphasizes empowering caregivers and enhancing the entire healthcare system's efficiency. Its mission is to leverage technology to create a personalized digital care ecosystem that benefits individuals, caregivers, providers, and payors by providing a longitudinal, data-rich view of patient care and support networks (Exa). The company's target market primarily includes healthcare organizations, senior care providers, and families involved in long-term care, with a focus on care transitions and at-home care environments.

HealthHive's core services include care coordination, system integration, and data management, designed to improve outcomes and reduce costs by fostering better communication and informed decision-making among care teams. With a small team of around four employees, the company is committed to advancing value-based care through innovative technology solutions that address the needs of aging populations and their support networks (Exa). Its value proposition centers on creating a more connected, informed, and efficient care ecosystem that supports aging in place and enhances quality of life.

Hive Health

Hive Health Weekly Intel Updates

Receive weekly intel updates about Hive Health straight to your inbox.

Competitors

Hive Health Competitors

Hive Health faces competition from several notable players in the digital health and health insurance sectors.

Fujifilm is a key competitor, leveraging its extensive healthcare imaging and diagnostic expertise to offer advanced medical imaging solutions and diagnostics, positioning itself strongly in clinical settings with a focus on innovation and high-quality imaging technology (Tracxn).

Access Healthcare is another significant rival, primarily known for its healthcare outsourcing and revenue cycle management services, which compete with Hive's integrated digital health and insurance offerings by providing comprehensive healthcare process solutions (Tracxn).

Centivo distinguishes itself with a focus on affordable, employer-centric health plans, emphasizing cost transparency and value-based care, which directly challenges Hive’s market positioning in small to medium enterprise health insurance (Tracxn).

AmplifyMD is a recent funding-backed competitor that specializes in virtual care and telehealth services, offering a platform that emphasizes rapid, scalable telemedicine solutions, positioning itself as a flexible alternative to Hive’s broader health platform (Tracxn). Additionally, Wizey and InsideTracker are indirect competitors in the health testing and personalized wellness space, providing blood analysis and health optimization services that appeal to health-conscious consumers and supplement Hive’s offerings (HealthTestReview, Wizey).

In terms of features, Hive offers a comprehensive digital health platform with services like teleconsultation, mental health support, and maternity benefits, targeting small and medium-sized businesses in the Philippines and beyond (CB Insights). Pricing strategies vary, with Hive focusing on B2B enterprise solutions, whereas competitors like InsideTracker and Wizey offer direct-to-consumer models with subscription-based or per-test pricing. Market share remains competitive, with Hive establishing a foothold in Southeast Asia and attracting significant investor interest, but it faces stiff competition from global players with more extensive resources and broader service portfolios (Tracxn).

Product & Pricing

Hive Health Product and Pricing Intelligence

Hive Health offers a variety of pricing plans tailored to different needs. The basic plan starts at $29 per month, with enterprise pricing available upon request, which may include volume discounts (Shyft). This plan provides access to telemedicine, customizable health insurance plans, and HR management tools designed specifically for Filipino SMBs. Additionally, Hive Health's platform emphasizes simplifying health benefits management and providing comprehensive coverage options.

For AI and digital platform solutions, Hive provides flexible, usage-based pricing models. Their plans include a free tier with $50+ in free credits and access to multiple models, suitable for developers and small teams. Enterprise plans are custom-priced and include premium support, multi-region deployment, and full access to all Hive models (thehive.ai).

Other related services, like Hive Tax Research, offer subscription plans starting at $79 per month for unlimited research and tax data access, with annual billing options providing savings. Meanwhile, project management tools from Hive have free plans with basic features and paid tiers starting at $5 per user per month, offering additional storage, unlimited projects, and advanced collaboration features (hive.com). Overall, Hive's pricing structure is designed to accommodate both small businesses and large enterprises, with tiered plans and customizable options to suit diverse needs.

Ad Campaigns

Hive Health Ad Campaigns

Hive Health is currently running 46 ads across Google, LinkedIn — 28 on Google and 18 on LinkedIn. Explore Hive Health's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Hive Health's ads

View ads

Hiring & Layoffs

Hive Health Hiring and Layoffs

Recent hiring trends at Hive Health indicate ongoing expansion, with multiple job openings across various departments such as healthcare, software, and operations. As of early 2026, the company continues to actively recruit, reflecting a strategic focus on scaling its team to support its mission of providing accessible healthcare solutions in the Philippines (Kalibrr, Built In). This sustained hiring activity suggests Hive Health’s commitment to growth, innovation, and market penetration, especially after raising $6.5 million in pre-Series A funding in mid-2024, which was aimed at expanding its healthcare network and technological capabilities (Our Hive Health).

In terms of layoffs, there is no recent publicly available information indicating any significant layoffs at Hive Health, which typically signals a stable or growth-oriented company strategy. The company's focus on expanding its team and technological investments aligns with a long-term vision to enhance healthcare access for small and medium-sized enterprises in the Philippines (MedCity News). Overall, Hive Health’s hiring patterns reflect a company in a growth phase, leveraging funding and strategic hiring to solidify its position in the healthcare industry and support its mission-driven expansion.

Leadership

Hive Health Management and Leadership Team

The leadership team at Hive includes key executives such as Kevin Guo, the Founder and CEO, and Dan Calpin, President of Hive's Enterprise AI division (theorg.com). As of 2022, Kevin Guo has been leading the company, with no recent publicly reported leadership changes or notable hires at the C-suite level since then (theorg.com).

According to a 2021 report, Hive's management team comprises seven executives and a board of directors, with Kevin Guo maintaining his role as CEO (cbinsights.com). There have been no recent updates indicating significant leadership changes or new high-level hires since that time.

In addition, a 2026 SEC filing mentions Hive Digital Technologies Ltd., but does not specify details about the leadership team or recent leadership changes (stocktitan.net). Overall, Hive's leadership remains centered around Kevin Guo and a core executive team, with no major recent shifts reported.

Financials

Hive Health Financial Performance, Fundraising, M&A

Hive Health has demonstrated significant financial activity recently, with a notable funding round of $6.5 million in Pre-Series A funding announced in July 2024. This funding was supported by prominent investors such as Gentree Fund, BEENEXT, Y Combinator, and others, indicating strong investor confidence (ourhivehealth.com). As of 2026, the company is actively expanding its operations, focusing on healthcare access for SMEs in the Philippines, though specific revenue figures and valuation details are not publicly disclosed.

In the broader digital health sector, Health In Tech reported robust financial results for 2025, with revenues reaching $33.3 million, a 71% increase year-over-year, and an adjusted EBITDA of $4.1 million, up 81% YoY. The company projects revenue growth to $45-50 million in 2026, reflecting strong financial health and growth trajectory (prnewswire.com). This indicates a healthy financial position with consistent revenue growth and positive EBITDA margins.

Regarding mergers and acquisitions (M&A) activity, the search results do not specify any recent M&A deals involving Hive Health or Health In Tech. However, the sector's increasing funding and revenue growth suggest ongoing consolidation and investment activity, typical of a rapidly expanding digital health industry. Overall, Hive Health is in a growth phase supported by substantial funding, while Health In Tech demonstrates strong financial performance, positioning both companies well for future expansion.

Partnerships

Hive Health Partnerships, Clients and Vendors

Hive Health has established a growing ecosystem of partnerships and enterprise clients focused on healthcare innovation and digital health solutions. Notably, Hive Health announced its Global Partner Program in January 2024, aimed at building strategic alliances with service providers and technology companies to expand its ecosystem and enhance healthcare delivery (hive.com). This program indicates a focus on technology integrations and collaborative growth within the healthcare technology space.

Hive Health's client base includes prominent healthcare organizations such as Allina Health, ECU Health, and Palomar Health, which have reported improved operational outcomes through Hive’s platform (thehivehealth.com). These partnerships demonstrate Hive’s role in transforming healthcare operations, particularly in the United States. Additionally, Hive’s involvement in innovative healthcare projects, such as the Horizon Europe research initiative to improve HIV and NCD care, highlights its ecosystem relationships across Europe and the US (hivehealth.eu).

Furthermore, Hive Health’s collaborations extend into digital health infrastructure and AI-driven solutions, exemplified by its recent partnership with Cohere to develop a healthcare-specific large language model (LLM), aimed at optimizing revenue cycle management (RCM) processes (globenewswire.com). This indicates Hive’s strategic engagement with advanced AI and technology vendors to enhance healthcare system efficiencies and ecosystem integration.

Events

Hive Health Event Participations

Research Hive actively participates in various health-related events, including conferences, trade shows, webinars, and community events. Notably, Hive was the lead sponsor of the Trust & Safety Summit 2025, held in London, UK, where they contributed through keynote presentations and panel discussions on content moderation and AI innovations (Hive). Additionally, Hive hosts and sponsors webinars such as the February 2026 session on sustaining community health programs in Kenya, focusing on HIV prevention efforts (HIVE Impact Network). They are also involved in regional events like the Precision in Practice conference at UCalgary in April 2026, which focuses on safer IV care and health systems transformation (AllEvents). Moreover, Hive supports innovation weeks such as BioHive Week in Utah, celebrating life sciences and healthcare innovation with events like BioHive Live, Demo Day, and awards ceremonies (BioHive). These activities demonstrate Hive’s commitment to engaging with the health community through a variety of impactful events.

Frequently Asked Questions

What does Hive Health's $6.5 million pre-Series A raise in mid-2024 signal about where the company is in its growth cycle, and is another round likely imminent?

Hive Health's July 2024 pre-Series A of $6.5 million — backed by Gentree Fund, BEENEXT, and Y Combinator — places the company squarely in early-stage scaling mode, not maturity. The funding was explicitly earmarked for expanding its healthcare network and technological capabilities for SMEs in the Philippines. Sustained hiring across healthcare, software, and operations roles into early 2026 suggests the capital is being actively deployed, and the absence of any disclosed revenue figures makes a Series A the logical next financing event to watch.

What does Hive Health's hiring pattern across healthcare, software, and operations tell us about which part of their business they're betting on?

Hive Health's simultaneous recruitment across healthcare delivery, software development, and operations as of early 2026 indicates a parallel build-out rather than a single focused bet — suggesting the company believes it needs to scale clinical supply, tech infrastructure, and operational capacity at the same time. This is consistent with a platform play for SMEs in the Philippines, where the bottleneck is not just technology but also provider network depth and benefits administration capacity. The breadth of hiring is a signal of ambition but also of execution risk at the current funding level.

How defensible is Hive Health's SME-focused positioning in the Philippines against competitors like Centivo, which pursues a similar employer-centric value-based care model?

Hive Health's core defensibility lies in geographic and market-segment specificity — it is built for Filipino SMBs, a segment underserved by global players. Centivo competes on affordable, employer-centric health plans with cost transparency, but its model is oriented toward the U.S. market. The more relevant competitive threat is local and regional insurtech players with existing distribution in Southeast Asia, not U.S.-headquartered challengers. That said, Hive's moat will depend on how quickly it builds network density and HR integration lock-in before better-capitalized regional entrants move down-market.

What does Hive Health's reported partnership with Cohere to build a healthcare-specific LLM signal about their product roadmap priorities?

The Cohere partnership to develop an RCM-native large language model indicates Hive Health is investing in AI-driven revenue cycle management as a near-term product priority, not just a long-term R&D bet. For an SME-focused health benefits platform, automating claims processing and RCM could meaningfully reduce operational costs and improve unit economics. This move also signals that Hive is positioning its platform as infrastructure for healthcare administration, not just a benefits marketplace — a strategic expansion of scope worth tracking.

Does Hive Health's Global Partner Program announcement signal a distribution pivot, and what does it mean for their direct-sales motion?

Launching a formal Global Partner Program in January 2024 suggests Hive Health is deliberately building an indirect distribution channel alongside any direct-sales effort, which is a common move for early-stage B2B health platforms seeking to scale reach without proportional headcount growth. By recruiting service providers and technology companies as channel partners, Hive can extend into SME accounts it would not reach cost-effectively through direct sales alone. The timing — shortly before the pre-Series A close — suggests the partner ecosystem was positioned as part of the growth story presented to investors.

What does Hive Health's entry-level pricing of $29 per month reveal about the economics of their SME target market and the risk of underpricing?

A $29/month starting price for a platform bundling telemedicine, health insurance, and HR management tools for Filipino SMBs is aggressively low, likely a market-penetration price designed to reduce switching friction for cost-sensitive small businesses. The risk is that at this price point, contribution margins per account are thin and the business requires significant volume to reach sustainable unit economics — a challenge that the $6.5 million pre-Series A would need to support during the scaling phase. Enterprise pricing available on request suggests Hive is betting that SME accounts graduate upward as their headcount grows.

What does the absence of any disclosed revenue figures or valuation for Hive Health mean for corp-dev teams evaluating it as an acquisition target?

The complete absence of disclosed revenue or valuation data means any M&A evaluation of Hive Health would require significant proprietary diligence, as there is no public financial baseline from which to anchor a deal thesis. The $6.5 million raise sets a rough floor for post-money valuation expectations, but Y Combinator and BEENEXT backing typically commands a meaningful premium to invested capital. For a corp-dev team, the more actionable signal is growth trajectory — hiring velocity and product expansion pace — rather than headline financials that don't yet exist in the public record.

What does Hive Health's Y Combinator backing signal about their competitive advantage relative to non-YC health benefits startups in Southeast Asia?

Y Combinator participation gives Hive Health access to a global alumni network, U.S. investor relationships, and a credibility signal that is disproportionately valuable in markets like the Philippines where institutional venture infrastructure is thinner. It also suggests the founding team cleared a selective bar for product-market fit at an early stage. For competitors without YC backing, the asymmetry is less about capital and more about the recruiting and partnership halo — which is meaningful when trying to close enterprise SME accounts that want a credible, durable vendor.

Is there any signal in Hive Health's hiring and funding activity that they are planning to expand beyond the Philippines in the near term?

The available signals are mixed but lean toward consolidation in the Philippines before broader expansion. The pre-Series A funding was explicitly framed around expanding the healthcare network in the Philippines, and hiring activity is concentrated on supporting that domestic mission. The Global Partner Program could be a precursor to regional expansion by using partners to enter adjacent Southeast Asian markets without a direct operational footprint, but there is no explicit evidence yet of a near-term country expansion plan.

What does the competitive set facing Hive Health — including Fujifilm, Access Healthcare, and AmplifyMD — suggest about how Hive is perceived in the market, and is that set accurately framed?

The competitive framing that includes Fujifilm and Access Healthcare alongside Hive Health suggests significant category confusion in how the company is being benchmarked — Fujifilm is a medical imaging hardware and diagnostics company, and Access Healthcare is a U.S.-focused RCM outsourcer, neither of which directly competes with an SME health benefits platform in the Philippines. The more meaningful competitive set is local Philippine health maintenance organizations, regional insurtechs, and employer benefits platforms operating in Southeast Asia. The fact that no direct Philippine-market competitors appear in available intelligence is itself a gap worth flagging.

What does the stability of Hive Health's leadership — with no reported C-suite turnover or major new hires since founding — signal about organizational maturity and potential scaling risks?

A stable founding team with no reported senior leadership changes can signal strong internal alignment and mission cohesion, which is valuable at the pre-Series A stage. However, it also raises the question of whether the executive bench has the functional depth — particularly in enterprise sales, regulatory affairs, and insurance underwriting — needed to execute the next phase of growth. Investors preparing for a Series A evaluation will likely probe whether the team needs to bring in experienced operators before or alongside the next raise.

What does Hive Health's product bundle — telemedicine, mental health support, maternity benefits, and HR management — suggest about their theory of why SMEs churn from health benefits providers?

Bundling telemedicine, mental health, maternity benefits, and HR administration into a single platform signals that Hive Health's thesis is that SME churn from health benefits is driven by administrative friction and gaps in coverage breadth, not primarily by price. By collapsing multiple vendor relationships into one interface, Hive increases switching costs and positions itself as the benefits operating system for the employer rather than a point solution. This is a high-retention strategy if execution holds, but it requires Hive to maintain quality across multiple clinical verticals simultaneously — a significant operational challenge at the current team size.

Powered by ForesightIQ · Competitive intelligence from digital exhaust